HOA TRAN: Open Payments
NPI 1912088089 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 21 payments from 13 companies in 2025. Trend: 2023 $481 · 2024 $703 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| GENZYME CORPORATION | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Insmed, Inc. | 2 | $33 |
| United Therapeutics Corporation | 1 | $25 |
| HARMONY BIOSCIENCES LLC | 1 | $23 |
Products named: DUPIXENT, NUCALA, INSPIRE, XYWAV, GLASSIA, Arikayce, WAKIX, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
